U.S., June 7 -- ClinicalTrials.gov registry received information related to the study (NCT07009327) titled 'Efficacy and Safety of Photodynamic Therapy for CIN3' on May 13.
Brief Summary: To investigate the efficacy and safety of photodynamic therapy (20% 5-amino-ketovalerate 630nm red light) in the treatment of cervical intraepithelial neoplasia 3(CIN 3)in women in the real world
Study Start Date: Jan. 01, 2024
Study Type: INTERVENTIONAL
Condition:
Precancerous Cervical Lesion
Intervention:
PROCEDURE: ALA-PDT
use ALA_PDT to treat the disease
Recruitment Status: RECRUITING
Sponsor: Peking University Third Hospital
Published by HT Digital Content Services with permission from Health Daily Digest....